Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / Breaking the Biomarker Bottlenecks Part 2
Oncology Bioinformatics Precision medicine Companion diagnostics Omics Technology and innovation Insights Opinion and Personal Narratives Molecular Pathology Voices in the Community

Breaking the Biomarker Bottlenecks: Part 2

Industry leaders from AstraZeneca, Leica Biosystems, and Danaher share their insights on AI’s power to democratize access to precision medicine

02/16/2026 Interview 6 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Oncology Diagnostics and AI-Powered Biomarker Analysis

Leading institutions leverage multidisciplinary expertise in oncology, pathology, computational biology, and artificial intelligence to develop and validate AI-driven diagnostic tools that improve biomarker detection, quantitative analysis, and personalized therapy selection.

  • #1

    Memorial Sloan Kettering Cancer Center

    New York, NY

    MSKCC is a leader in integrating AI with pathology and oncology, pioneering AI-driven biomarker discovery and precision medicine approaches to optimize cancer treatment selection and monitoring.

    Key Differentiators

    • Oncology
    • Pathology
    • Computational Biology
    • Artificial Intelligence
  • #2

    Dana-Farber Cancer Institute

    Boston, MA

    Dana-Farber combines cutting-edge cancer research with AI technologies to enhance biomarker identification and therapy personalization, with strong collaborations in computational pathology.

    Key Differentiators

    • Oncology
    • Cancer Genomics
    • AI in Medicine
  • #3

    Stanford University School of Medicine

    Stanford, CA

    Stanford is at the forefront of AI research applied to cancer diagnostics, developing novel computational pathology tools and multi-omic biomarker integration for precision oncology.

    Key Differentiators

    • Biomedical Informatics
    • Oncology
    • Artificial Intelligence
  • #4

    Johns Hopkins Medicine

    Baltimore, MD

    Johns Hopkins integrates pathology expertise with AI to improve biomarker quantification and therapy response monitoring, emphasizing translational research and clinical implementation.

    Key Differentiators

    • Pathology
    • Oncology
    • Computational Medicine
  • #5

    MD Anderson Cancer Center

    Houston, TX

    MD Anderson is a global leader in cancer research with significant investments in AI to enhance biomarker discovery, diagnostics, and personalized treatment strategies.

    Key Differentiators

    • Cancer Research
    • Pathology
    • AI in Oncology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Helping Hand from AI in Prostate Cancer Diagnostics
Precision medicine
A Helping Hand from AI in Prostate Cancer Diagnostics

February 8, 2022

3 min read

Using AI to enhance personalized healthcare for patients with prostate cancer

The Ultimate Vision for Rare Disease
Precision medicine
The Ultimate Vision for Rare Disease

February 28, 2022

1 min read

Genomics and computational pathology can take rare disease diagnostics to the next level

A Light in the Darkness
Precision medicine
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

In-House Matters
Precision medicine
In-House Matters

April 7, 2022

3 min read

Molecular pathology is complex – and the benefits of keeping it local are extensive

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.